大肠直肠癌知多少课件.pptVIP

* * * * * * * * * * * * * * * * Despite scientific and cost effectiveness data supporting screening for CRC, screening rates remain low. These are data from CDC’s Behavioral Risk Factor Surveillance System (BRFSS). This graph shows reported rates of use of FOBT and flexible sigmoidoscopy/colonoscopy from 1999. Mammography and Pap smear usage is shown for comparison. These are not direct comparisons. The corresponding populations differ. FOBT and CRC rates were calculated among men and women 50 and older. Mammogram and Pap smear rates were calculated only among women, those over 40 who reported receiving a mammogram within the past 2 years, and those over 18 who reported receiving a Pap smear within 3 years. None-the-less, this graph illustrates that CRC screening tests are being utilized at rates far lower than other well-accepted screening tests.These age groupings reflect the population that should be getting regular screening. For FOBT, only 21 % of adults over 50 had completed the test within the past year; for flexible sigmoidoscopy, only 34 % had completed the test within the past five years. These self-reported rates may include tests done for diagnostic purposes and likely overestimate the extent of regular screening being performed. Compare these numbers with the higher levels of mammography and Pap smear screening–74% within the past two years and 82% within the past three years, respectively. So, we really need to do a better job getting people screened for colorectal cancer. * * * * * * * * * * * * HARTMANNS’ PROCEDURE 腹部會陰切除術 人工造口 * * * * * * * * * Slide courtesy of CDC-”Call to Action” The majority of colorectal cancers, 65% to 85%, occur in people with no known cause (i.e., they are considered sporadic). 10% to 30% of cases of colorectal cancer occur in people who have a family member who has had a polyp or colorectal cancer. A small percentage of colorectal cancers occur as part of an inherited syndrome. Approximately 5% are associated with heredita